Letters, calls and emails: Drug companies do not need NHS help

Dear Editor

Dr John Sharvill may be on to something when raising the possibility of central funding to solve the problems raised by over-paying for drugs when there are generic drugs in the class (GP, 17 November).  

‘Reference pricing’ has been used to peg reimbursement prices to the cost of the equivalent generic drug in many countries.  

If patients want the on-patent drug they can pay a ‘co-payment’ towards it — few take this up. This would solve the problem of switching at source.  

Implantable cardiac defibrillators (ICDs) were also covered in the same issue of GP. These cost around £16,000 each and last seven years. Does it make sense that we pay premium prices for old technology and then struggle to fund new advances like ICDs? Maybe a unified cardiovascular budget would help.  

Paying over the odds won’t stimulate innovation or research any more than motorists making voluntary overpayments for petrol would encourage oil exploration — why bother looking?   

The NHS can’t afford to give hand-outs to businesses that don’t need charity.  

The drugs industry spends up to three times more on marketing than on research and has some of the highest profit margins of any sector.  

It generally does a good job, but our relationship with it must be balanced and healthy.  

Dr Rubin Minhas  

Primary care CHD clinical lead, Medway PCT 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Follow Us:

Just published

Houses of Parliament

GP partnerships 'like collapsing Jenga stack' after Javid threat to nationalise practices

Sajid Javid's decision to back a report calling for the end of the GMS contract within...

£20 notes spread out

VAT trap for PCNs could strip millions of pounds from general practice

Tens of millions of pounds could be stripped from general practice because work carried...

Talking General Practice logo

Podcast: Is the BMA representing GPs effectively, why GPs face a pension tax hit, and views on the workload crisis

In our regular news review the team discusses representation of GPs, a new survey...

Man sleeping

NICE guidance on insomnia backs app to replace sleeping pills

Hundreds of thousands of people with insomnia could be offered treatment via a mobile...

Health worker prepares a dose of COVID-19 vaccine

JCVI backs autumn COVID-19 booster campaign for high-risk adults and NHS staff

Frontline health and social care staff and adults at increased risk of severe illness...

GP consultation

Government accused of 'misleading' claims on general practice workforce

GP leaders have accused the government of making misleading claims about the general...